Upload Avatar (500 x 500)
Li Wei
liwei@ioz.ac.cn
English, Chinese
Beijing
Chinese Academy of Sciences
Institute of Zoology
  • 2006 - Bachelor of Science: Wuhan University
  • 2012 - Doctor of Science: University of Chinese Academy of Sciences
  • Published over 60 papers in journals like Cell, Science, Nature
  • Granted over 20 invention patents
  • Research selected multiple times for 'Top Ten Advances in Chinese Science' and 'Top Ten Advances in Chinese Life Sciences'
  • Several gene and cell therapy drugs based on work progress have entered clinical trial stages
  • 2013 - Present: Chinese Academy of Sciences, Institute of Zoology
  • National Outstanding Youth Science Fund
  • Excellent Youth Science Fund
  • International Award from the Japanese Society for Laboratory Animal Science
  • Youth Scientist Award from the Chinese Academy of Sciences
  • Outstanding Scientific Achievement Award (Outstanding Contributor) from the Chinese Academy of Sciences
  • Zhu Li Yuehua Excellent Teacher Award from the Chinese Academy of Sciences
Development of mammalian engineering biology as a new enabling platform
Exploration of mechanisms and pathways for mammalian organ regeneration and repair
Development of new biological treatment methods for major diseases
  • All-RNA-mediated targeted gene integration in mammalian cells with rationally engineered R2 retrotransposons, Chen Y, Luo S, Hu Y, Mao B, Wang X, Lu Z, Shan Q, Zhang J, Wang S, Feng G, Wang C, Liang C, Tang N, Niu R, Wang J, Han J, Yang N, Wang H, Zhou Q, Li W, 2024
  • Therapeutic In Vivo Gene Editing Achieved by a Hypercompact CRISPR-Cas12f1 System Delivered with All-in-One Adeno-Associated Virus, Cui T, Cai B, Tian Y, Liu X, Liang C, Gao Q, Li B, Ding Y, Li R, Zhou Q, Li W, Teng F, 2024
  • High-efficiency targeted transgene integration via primed micro-homologues, Wang C, Fang S, Chen Y, Tang N, Jiao G, Hu Y, Li J, Shan Q, Wang X, Feng G, Zhou Q, Li W, 2023
  • A sustainable mouse karyotype created by programmed chromosome fusion, Wang LB, Li ZK, Wang LY, Xu K, Ji TT, Mao YH, Ma SN, Liu T, Tu CF, Zhao Q, Fan XN, Liu C, Wang LY, Shu YJ, Yang N, Zhou Q, Li W, 2022
  • Synergistic engineering of CRISPR-Cas nucleases enables robust mammalian genome editing, Chen Y, Hu Y, Wang X, Luo S, Yang N, Chen Y, Li Z, Zhou Q, Li W, 2022
  • Pharmacological Perturbation of Mechanical Contractility Enables Robust Transdifferentiation of Human Fibroblasts into Neurons, He ZQ, Li YH, Feng GH, Yuan XW, Lu ZB, Dai M, Hu YP, Zhang Y, Zhou Q, Li W, 2022
  • Metagenomic discovery of novel CRISPR-Cas13 systems, Hu Y, Chen Y, Xu J, Wang X, Luo S, Mao B, Zhou Q, Li W, 2022
  • SARS-CoV-2 detection with CRISPR diagnostics, Guo L, Sun X, Wang X, Liang C, Jiang H, Gao Q, Dai M, Qu B, Fang S, Mao Y, Chen Y, Feng G, Gu Q, Wang RR, Zhou Q, Li W, 2020
  • Overcoming Intrinsic H3K27me3 Imprinting Barriers Improves Post-implantation Development after Somatic Cell Nuclear Transfer, Wang LY, Li ZK, Wang LB, Liu C, Sun XH, Feng GH, Wang JQ, Li YF, Qiao LY, Nie H, Jiang LY, Sun H, Xie YL, Ma SN, Wan HF, Lu FL, Li W, Zhou Q, 2020
  • Treating Bietti crystalline dystrophy in a high-fat diet-exacerbated murine model using gene therapy, Qu B, Wu S, Jiao G, Zou X, Li Z, Guo L, Sun X, Huang C, Sun Z, Zhang Y, Li H, Zhou Q, Sui R, Li W, 2020
  • Rapid construction of a whole-genome mutant library by combining haploid stem cells and inducible self-inactivating PiggyBac transposon, Mao J, Xu K, Han J, Feng G, Zhang Y, Li W, 2020
  • CDetection: CRISPR-Cas12b-based DNA detection with sub-attomolar sensitivity and single-base specificity, Teng F, Guo L, Cui T, Wang XG, Xu K, Gao Q, Zhou Q, Li W, 2019
  • Enhanced mammalian genome editing by new Cas12a orthologs with optimized crRNA scaffolds, Teng F, Li J, Cui T, Xu K, Guo L, Gao Q, Feng G, Chen C, Han D, Zhou Q, Li W, 2019
  • Cyclin B3 is required for metaphase to anaphase transition in oocyte meiosis I, Li Y, Wang L, Zhang L, He Z, Feng G, Sun H, Wang J, Li Z, Liu C, Han J, Mao J, Li P, Yuan X, Jiang L, Zhang Y, Zhou Q, Li W, 2019
  • Asymmetric expression of LincGET biases cell fate in two-cell mouse embryos, Wang J, Wang L, Feng G, Wang Y, Li Y, Li X, Liu C, Jiao G, Huang C, Shi J, Zhou T, Chen Q, Liu Z, Li W, Zhou Q, 2018
  • Repurposing CRISPR-Cas12b for mammalian genome engineering, Teng F, Cui T, Feng G, Guo L, Xu K, Gao Q, Li T, Li J, Zhou Q, Li W, 2018
  • SIRT6 deficiency results in developmental retardation in cynomolgus monkeys, Zhang W, Wan H, Feng G, Qu J, Wang J, Jing Y, Ren R, Liu Z, Zhang L, Chen Z, Wang S, Zhao Y, Wang Z, Yuan Y, Zhou Q, Li W, Liu G, Hu B, 2018
  • Generation of bimaternal and bipaternal mice from hypomethylated haploid escs with imprinting region deletions, Li ZK, Wang LY, Wang LB, Feng GH, Yuan XW, Liu C, Xu K, Li YH, Wan HF, Zhang Y, Li YF, Li X, Li W, Zhou Q, Hu BY, 2018
  • Mettl3-mediated m6A regulates spermatogonial differentiation and meiosis initiation, Xu K, Yang Y, Feng GH, Sun BF, Chen JQ, Li YF, Chen YS, Zhang XX, Wang CX, Jiang LY, Liu C, Zhang ZY, Wang XJ, Zhou Q, Yang YG, Li W, 2017
  • Generation and application of mouse-rat allodiploid embryonic stem cells, Li X, Cui XL, Wang JQ, Wang YK, Li YF, Wang LY, Wan HF, Li TD, Feng GH, Shuai L, Li ZK, Gu Q, Hao J, Wang L, Zhao XY, Liu ZH, Wang XJ, Li W, Zhou Q, 2016
  • One-step generation of p53 gene biallelic mutant Cynomolgus monkey via the CRISPR/Cas system, Wan HF, Feng CJ, Teng F, Yang SH, Hu BY, Niu YY, Xiang P, Fang WZ, Ji WZ, Li W, Zhao XY, Zhou Q, 2015
  • Genetic modification and screening in rat using haploid embryonic stem cells, Li W, Li X, Li TD, Jiang MG, Wan HF, Luo GZ, Feng CJ, Cui XL, Teng F, Yuan Y, Zhou Q, Gu Q, Shuai L, Sha JH, Xiao YM, Wang L, Liu ZH, Wang XJ, Zhao XY, Zhou Q, 2014
  • Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems, Li W, Teng F, Li T, Zhou Q, 2013
  • Androgenetic haploid embryonic stem cells produce live transgenic mice, Li W, Shuai L, Wan H, Dong M, Wang M, Sang L, Feng C, Luo GZ, Li T, Li X, Wang L, Zheng QY, Sheng C, Wu HJ, Liu Z, Liu L, Wang L, Wang XJ, Zhao XY, Zhou Q, 2012
  • iPS cells produce viable mice through tetraploid complementation, Zhao XY, Li W, Lv Z, Liu L, Tong M, Hai T, Hao J, Guo CL, Ma QW, Wang L, Zeng F, Zhou Q, 2009
Mammalian Engineering Biology Organ Regeneration Gene Therapy Cell Therapy Synthetic Biology Biological Treatment Disease Treatment Genetic Engineering Cell Engineering Clinical Trials

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.